USAID & Partners Announce $6 Billion to Fight NTDs
Last week, the U.S. Agency for International Development (USAID) announced new partnerships to help countries eliminate and control neglected tropical diseases (NTDs). Over the next five years, new and expanded partnerships will provide 1.3 billion treatments, leverage $6 billion in donated drugs, and prevent more than 585 million people from needing treatment for NTDs. This new commitment will help eliminate Trachoma, the world’s leading cause of preventable blindness, and combat Lymphatic Filariasis, a painful and disfiguring parasitic infection transmitted by mosquitos. In addition, USAID will promote improved sanitation to break the transmission of diseases like Schistosomiasis, caused by a painful abdominal parasite. NTDs affect approximately one billion people worldwide. Read more on this initiative.
PATH Releases New Advocacy Papers
PATH recently launched a new series of papers on market strengthening for maternal health. The paper series, titled “Stronger markets, increased access to maternal health supplies,” details how key market challenges, such as inconsistent availability and poor-quality supplies of oxytocin, misoprostol, and magnesium sulfate, are putting women’s lives at risk, and what can be done to solve the problem. Written by PATH in partnership with the Reproductive Health Supplies Coalition (RHSC) and Results for Development Institute (R4D), the papers provide details and recommended actions in three geographies: globally and in Bangladesh and Nigeria. Read the papers.
CDC Calls for Research Proposals
The Centers for Disease Control and Prevention (CDC) seeks proposals to conduct innovative research to improve the ability of CDC and its partners to effectively respond to public health outbreaks, conduct research, and perform disease prevention and control activities. CDC anticipates that the knowledge resulting from awards made under this announcement will contribute significantly to the evidence base for prevention and control of vector-borne diseases. Deadline for submission is October 20. Read CDC’s Broad Agency Announcement (BAA) for more details.
A Conversation with WHO Director-General Candidate
On September 28, The Center for Strategic and International Studies (CSIS) hosted a conversation with Philippe Douste-Blazy, Under-Secretary-General of the United Nations and Special Advisor to the Secretary-General on Innovative Financing for Development, on his candidacy for Director-General of the World Health Organization (WHO). The former French politician is one of six candidates nominated for the position. The election process which began in April 2016 will conclude with member states casting their votes for one of the final three nominees during the 70th Session of the World Health Assembly (WHA) in May 2017. Access the recording of CSIS’s conversation with Philippe Douste-Blazy.